You have 9 free searches left this month | for more free features.

HRVO

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion Trial in Palo Alto (nicotinic acid)

Terminated
  • Central Retinal Vein Occlusion
  • Branch Retinal Vein Occlusion
  • nicotinic acid
  • Palo Alto, California
    Palo Alto Medical Foundation Department of Ophthalmology
Oct 21, 2019

Macular Edema, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham

Active, not recruiting
  • Macular Edema
  • +2 more
  • Mesa, Arizona
  • +193 more
Jul 25, 2022

Retinal Vein Occlusion Trial in Palo Alto (Nicotinic acid, Prednisolone acetate)

Completed
  • Retinal Vein Occlusion
  • Nicotinic acid
  • Prednisolone acetate
  • Palo Alto, California
    Palo Alto Medical Foundation Department of Ophthalmology
Dec 18, 2018

Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions Trial in Houston, Katy, The Woodlands (0.5mg Ranibizumab, Targeted

Completed
  • Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
  • 0.5mg Ranibizumab
  • Targeted Pan Retinal Photocoagulation
  • Houston, Texas
  • +2 more
Aug 8, 2017

Retinal Vein Occlusion, Macular Edema Trial (ranibizumab, Squalamine Lactate Ophthalmic Solution, 0.2%)

Completed
  • Retinal Vein Occlusion
  • Macular Edema
  • (no location specified)
Nov 24, 2015